Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Syringes cost pennies each
Symptoms include tiredness, weakness, shortness of breath with mild exertion, and cold hands and feet
As of August 2026, all four core Phase 3 TRIUMPH trials for retatrutide (Eli Lillys triple agonist targeting GLP-1, GIP, and glucagon receptors) have reported strong efficacy data, including up to 28.7% mean weight loss and cardiovascular benefits
3 However, the active forms of GLP-1 have a very short plasma half-life (less than 2 minutes) due to rapid degradation by the enzyme dipeptidyl peptidase-4 (DPP-4)
GLP-1 is a type of incretin hormone, meaning its created in the gut and released after eating a meal
US$ 21.52
US$ 24.14
US$ 28.96
